{"address1": "Sinopharm Group Building", "address2": "No. 385, East Longhua Road Huangpu District", "city": "Shanghai", "zip": "200023", "country": "China", "phone": "86 21 2305 2666", "fax": "86 21 2305 2888", "website": "https://www.sinopharmgroup.com.cn", "industry": "Medical Distribution", "industryKey": "medical-distribution", "industryDisp": "Medical Distribution", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. operates as a subsidiary of Sinopharm Industrial Investment Co., Ltd.", "fullTimeEmployees": 114766, "companyOfficers": [{"maxAge": 1, "name": "Mr. Qingming  Yu", "age": 59, "title": "Executive Chairman of the Board", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 7051416, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yong  Liu", "age": 54, "title": "President & Executive Director", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 6818904, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Xiaojuan  Li", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1976, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Yijian  Wu", "age": 53, "title": "Secretary to the Board, Company Secretary & Authorised Representative", "yearBorn": 1970, "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 6, "boardRisk": 9, "compensationRisk": 2, "shareHolderRightsRisk": 9, "overallRisk": 7, "governanceEpochDate": 1709251200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 3, "previousClose": 20.65, "open": 20.7, "dayLow": 20.7, "dayHigh": 21.3, "regularMarketPreviousClose": 20.65, "regularMarketOpen": 20.7, "regularMarketDayLow": 20.7, "regularMarketDayHigh": 21.3, "dividendRate": 0.9, "dividendYield": 0.0429, "exDividendDate": 1687132800, "payoutRatio": 0.2967, "fiveYearAvgDividendYield": 3.75, "beta": 0.837, "trailingPE": 6.885246, "forwardPE": 6.0, "volume": 3170802, "regularMarketVolume": 3170802, "averageVolume": 4902348, "averageVolume10days": 4134714, "averageDailyVolume10Day": 4134714, "bid": 21.0, "ask": 21.05, "marketCap": 65533857792, "fiftyTwoWeekLow": 17.44, "fiftyTwoWeekHigh": 28.45, "priceToSalesTrailing12Months": 0.11075789, "fiftyDayAverage": 20.8766, "twoHundredDayAverage": 21.3567, "trailingAnnualDividendRate": 0.82, "trailingAnnualDividendYield": 0.039709445, "currency": "HKD", "enterpriseValue": 154208550912, "profitMargins": 0.01481, "floatShares": 1341663716, "sharesOutstanding": 1341810048, "heldPercentInsiders": 0.000120000004, "heldPercentInstitutions": 0.61721003, "impliedSharesOutstanding": 3120659968, "bookValue": 22.997, "priceToBook": 0.9131626, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "earningsQuarterlyGrowth": -0.079, "netIncomeToCommon": 8765042688, "trailingEps": 3.05, "forwardEps": 3.5, "pegRatio": 0.47, "enterpriseToRevenue": 0.261, "enterpriseToEbitda": 6.271, "52WeekChange": -0.09030837, "SandP52WeekChange": 0.32311738, "lastDividendValue": 0.901099, "lastDividendDate": 1687132800, "exchange": "HKG", "quoteType": "EQUITY", "symbol": "1099.HK", "underlyingSymbol": "1099.HK", "shortName": "SINOPHARM", "longName": "Sinopharm Group Co. Ltd.", "firstTradeDateEpochUtc": 1253669400, "timeZoneFullName": "Asia/Hong_Kong", "timeZoneShortName": "HKT", "uuid": "3aab8c03-89ab-3ccd-a5a1-1c7ea1125270", "messageBoardId": "finmb_62494979", "gmtOffSetMilliseconds": 28800000, "currentPrice": 21.0, "targetHighPrice": 32.76, "targetLowPrice": 20.8, "targetMeanPrice": 27.58, "targetMedianPrice": 27.41, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 13, "totalCash": 44263804928, "totalCashPerShare": 14.184, "ebitda": 24589561856, "totalDebt": 88770011136, "quickRatio": 1.058, "currentRatio": 1.337, "totalRevenue": 591685681152, "debtToEquity": 76.57, "revenuePerShare": 189.832, "returnOnAssets": 0.03486, "returnOnEquity": 0.13147001, "freeCashflow": -1701624832, "operatingCashflow": 12721900544, "earningsGrowth": -0.075, "grossMargins": 0.08211, "ebitdaMargins": 0.04156, "operatingMargins": 0.032560002, "financialCurrency": "CNY", "trailingPegRatio": 30.462}